The endotoxin-induced coagulant activity of human monocytes

British Journal of Haematology
R P RiversW L Weston

Abstract

Leucocyte suspensions, exposed to endotoxin in vitro, develop coagulant activity which has been identified as tissue factor. Pure suspensions of polymorphonuclear (PMN) neutrophils, lymphocytes and monocytes were exposed to endotoxin and tested for tissue factor activity after 4 h incubation at 37 degrees C. The results indicate that the monocyte is the cell primarily responsible for the endotoxin-induced coagulant activity of mixed leucocyte suspensions, the small amount of activity demonstrated in PMN neutrophil and in lymphocyte suspensions at high cell concentrations being accounted for by monocyte contamination of less than 1%.

References

Feb 1, 1972·The Journal of Clinical Investigation·J Niemetz
Jun 1, 1973·The Journal of Clinical Investigation·F R RicklesM E Conrad
Oct 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·R G LernerK Lange
Mar 1, 1971·Transplantation·D P Sengar, P I Terasaki
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·A Agnoli
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation·A Gottfries
Jan 1, 1968·The Journal of Clinical Investigation·Y Nemerson

❮ Previous
Next ❯

Citations

Jan 1, 1986·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·S M Almdahl, B Osterud
Jan 1, 1978·Agents and Actions·A C AllisonH U Schorlemmer
Jan 6, 1999·Archives of Pharmacal Research·Y N Han, I K Rhee
Feb 24, 2001·International Journal of Clinical & Laboratory Research·L PuccettiA L Pasqui
Jul 8, 2010·Internal and Emergency Medicine·Giovanni CimminoJuan Jose Badimon
Dec 27, 1985·Journal of Immunological Methods·L M MorriceA W Thomson
Jan 1, 1996·Thrombosis Research·E CamererH Prydz
Feb 15, 1996·Thrombosis Research·P SchmidH Sinzinger
Mar 1, 1996·Thrombosis Research·A C StephensR P Rivers
Jan 1, 1996·Leukemia Research·G A HairF R Rickles
Jan 1, 1992·General Pharmacology·H C LeeB K Lum
Jan 1, 1991·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·A J Chu
Mar 9, 2004·Blood Cells, Molecules & Diseases·Saskia H H F SchoenmakersC Arnold Spek
Feb 18, 2004·Thrombosis Research·Anders MälarstigAgneta Siegbahn
Mar 1, 1997·Thrombosis Research·A C Stephens, R P Rivers
Nov 15, 1997·Thrombosis Research·T TennoA Siegbahn
Jul 25, 1998·Thrombosis Research·D M MartinH Prydz
Aug 12, 2005·Current Surgery·Eric J HanlyBrian D Peyton
Jun 29, 2001·British Journal of Pharmacology·A J ChuS Beydoun
Jan 25, 2003·Scandinavian Journal of Immunology·L F Flores-SuárezF J Van Der Woude
Feb 25, 2000·Surgery·H TodorokiK Ohsato
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R Bach, D B Rifkin
May 1, 1980·The Journal of Experimental Medicine·G A Levy, T S Edgington
Feb 1, 1978·British Journal of Haematology·N SemerraroJ Vermylen
Jul 1, 1979·British Journal of Haematology·S G RichardsonJ Stuart
Dec 1, 1988·British Journal of Haematology·J Niemetz, S Kang
Dec 1, 1995·British Journal of Haematology·P W CollinsK L Yong
Apr 5, 1983·European Journal of Biochemistry·R T Dean, H Prydz
Jan 1, 1991·Annals of the New York Academy of Sciences·S I Rapaport

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.